Barclays Lifts Bloom Energy Price Target to $308 on Production and Utility Catalysts

Barclays increased its price target on Bloom Energy (NYSE: BE) to $308 from a previous $276, pointing to a major manufacturing expansion and a strategic shift into the utility sector. In a research note, the firm maintained its Equal-Weight rating on the stock, which rose 3.75% in premarket trading following the report.

Manufacturing Capacity Set to Double

The upgraded outlook is partly driven by Bloom Energy's acquisition of a second manufacturing facility in Fremont, California. The new 158,000-square-foot site is nearly identical in size to the company's existing plant and could effectively double its production output.

According to Barclays analyst Christine Cho, this expansion provides a clear path for Bloom to increase its manufacturing capacity from the current 5–6 GW to approximately 10–12 GW. The note cautioned that while this addresses concerns about Bloom's internal capacity, investors should still monitor the company's supply chain to ensure it can scale in tandem with the new facility.

Landmark Utility Shift Broadens Market

Barclays also highlighted a significant development in the utility market. Ameren Missouri recently filed a 20-year Integrated Resource Plan (IRP) that includes a provision for 500 MW of natural gas fuel cells by 2030. Barclays believes Bloom Energy is the only supplier currently capable of executing a project of this scale.

Ad

This move is seen as a pivotal expansion for Bloom beyond its traditional "behind-the-meter" business, where it provides on-site power for individual facilities. The IRP opens the door to a "front-of-the-meter" model, positioning Bloom's fuel cells as primary generation assets that supply the main power grid, materially broadening its total addressable market.

Outlook and Analyst Commentary

The firm also addressed potential investor concerns regarding Project Jupiter, an Oracle data center initiative, where fuel cell deliveries could be affected by construction delays. Barclays suggests Oracle is more likely to take delivery and redirect the units to other projects rather than risk losing its place in Bloom's production queue.

Despite the positive catalysts and a backlog that continues to grow faster than revenue, Barclays maintained its Equal-Weight rating. The new $308 price target implies an upside of approximately 11% from the stock's last closing price.